Related Experiment Video
Updated: May 8, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Multivessel coronary revascularization and outcomes in kidney transplant recipients
Colin R Lenihan1, Maria E Montez-Rath, Wolfgang C Winkelmayer
1Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
Insights
For kidney transplant patients with multivessel coronary artery disease, coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) showed similar long-term survival and reduced risk of death or myocardial infarction.
Area of Science:
- Cardiology
- Nephrology
- Transplantation
Background:
- Coronary artery disease (CAD) is a significant cause of illness and death in kidney transplant recipients.
- Multivessel coronary disease requires revascularization, with choices between coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI).
Purpose of the Study:
- To compare the long-term outcomes of CABG versus PCI in US kidney transplant recipients with multivessel coronary disease.
- To evaluate the association of revascularization type with mortality and the composite of death or myocardial infarction (MI).
Main Methods:
- Retrospective cohort study using the US Renal Data System (1997-2009).
- Included adult kidney transplant patients with at least 6 months of Medicare A+B coverage undergoing first multivessel coronary revascularization.
- Compared outcomes using proportional hazards regression and propensity score-matched analyses.
Main Results:
- 2272 patients were analyzed: 1594 (69%) underwent CABG and 678 (31%) underwent PCI.
- The estimated 5-year survival rate was 55% across both groups.
- No significant difference was found between CABG and PCI for death (aHR=1.08) or the composite of death/MI (aHR=1.07).
Conclusions:
- In kidney transplant recipients with multivessel coronary disease, CABG and PCI offer comparable long-term survival.
- Neither revascularization strategy demonstrated superiority in reducing the composite endpoint of death or myocardial infarction.
Abstract:
Coronary artery disease is a major cause of morbidity and mortality in the kidney transplant population. We compared the long-term outcomes of coronary artery bypass graft (CABG) surgery with percutaneous coronary intervention (PCI) for multivessel coronary disease in a contemporary cohort of US kidney transplant recipients. From the U.S. Renal Data System, we identified all adult kidney transplant patients with ≥6 months of Medicare A+B undergoing first recorded multivessel coronary revascularization from 1997 to 2009. The associations of CABG versus PCI with death and the composite of death or myocardial infarction (MI) were compared using proportional hazards regression. Of the 2272 patients included in the study, 1594 underwent CABG and 678 underwent PCI. The estimated 5-year survival rate was 55% [95% confidence interval (CI) 53% to 57%] following coronary revascularization, with no significant association between revascularization type and death [adjusted hazard ratio (aHR) = 1.08; CI 0.94-1.23] or the composite of death or MI (aHR = 1.07; CI 0.96-1.18). Separate propensity score-matched analyses yielded similar results. In this analysis of kidney transplant recipients undergoing multivessel coronary revascularization, we found no difference between CABG and PCI in terms of survival or the composite of death and MI.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Kidney Injury I: Introduction

